Stock & Company Details
Madrigal Pharmaceuticals Inc $MDGL
Price:
N/A
N/A
23M
$11B
52 Week High:
N/A
10 Day Average Volume:
N/A
-37.06
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
MDGL technical indicators
Latest Madrigal Pharmaceuticals Inc (MDGL) indicator readings as of 2026-10-09.
MDGL's 14-day RSI is 26.8, in oversold territory. At $471.75 it is trading 7.2% below its 200-day moving average of $508.55, and below its 50-day average of $518.29. Price sits below the lower Bollinger Band ($473.57 to $546.22). ADX reads 28.8, indicating a trending market.
MDGL backtested strategy results
How 4 rule-based strategies performed on Madrigal Pharmaceuticals Inc (MDGL) over recent history, last backtested 2026-09-06. Select a strategy to plot its trades on the chart above. Past performance does not predict future results.
| Strategy | Equity curve | Return | Win rate | Trades | Max drawdown |
|---|---|---|---|---|---|
| Oversold Bounce Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | +234.1% | 33% | 12 | -43.0% | |
| Momentum Crossover Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | -67.1% | 26% | 35 | -83.1% | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | -38.1% | 29% | 34 | -69.9% | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | -57.6% | 39% | 28 | -77.8% |
Overview
Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.
Finance Bot
Ask your questions
Start by typing a question below.
